Acme United vs CompX International
ACU and CIX side by side, both in cutlery, handtools, and general hardware. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACU and CIX compare
CompX International is the larger company, worth 2.1 times as much as Acme United ($543M against $262M).
On earnings, CompX International is cheaper: it trades at 23.3× trailing earnings, against 25.2× for Acme United.
Acme United grew revenue faster over the last twelve months (13.1% versus 4.3% for CompX International).
CompX International keeps more of each dollar of sales as profit, with a net margin of 14.0% compared with 5.1% at Acme United.
Both pay dividends: Acme United yields 0.93% and CompX International 2.7%.
CompX International scores higher on the StockData Score (16 against 15 for Acme United), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACU | CIX |
|---|---|---|
| Size and price | ||
| Market cap | $262M | $543M |
| Share price | $68.46 | $43.98 |
| Change, 1 year | 87.3% | 99.8% |
| Change, 5 years | 90.2% | 95.6% |
| Beta (5Y) | 0.46 | 0.86 |
| Employees | 649 | 549 |
| StockData Score | ||
| Total score | 15 | 16 (better) |
| Valuation score | 0 | 0 |
| Growth score | 4 (better) | 2 |
| Performance score | 1 | 5 (better) |
| Health score | 6 | 6 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 25.2× | 23.3× (better) |
| P/S | 1.2× (better) | 3.3× |
| P/B | 2.1× (better) | 3.7× |
| EV/EBITDA | 12.0× (better) | 15.4× |
| P/FCF | 19.0× (better) | 22.9× |
| PEG | 0.56 | – |
| FCF yield | 5.3% (better) | 4.4% |
| Fair value | $56.81 | $29.43 |
| Margin of safety | −20.5% (better) | −49.5% |
| Growth | ||
| Revenue growth (TTM) | 13.1% (better) | 4.3% |
| Revenue growth, 5Y average | 3.7% | 6.7% (better) |
| Net income growth (TTM) | 13.3% | 19.8% (better) |
| EPS growth (TTM) | 11.5% | 20.4% (better) |
| EPS growth, 5Y average | 1.5% | 13.7% (better) |
| Profitability | ||
| Gross margin | 41.7% (better) | 32.5% |
| Operating margin | 7.2% | 16.9% (better) |
| Net margin | 5.1% | 14.0% (better) |
| FCF margin | 6.3% | 14.3% (better) |
| Return on equity | 9.4% | 16.3% (better) |
| Return on invested capital | 9.5% | 23.4% (better) |
| Financial health | ||
| Debt / equity | 0.22 (better) | 0.00 |
| Net debt / EBITDA | 0.86 | – |
| Interest coverage | 7.7× | – |
| Current ratio | 3.89 | 5.39 (better) |
| Altman Z-score | 4.45 | 17.93 (better) |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | 0.93% | 2.7% (better) |
| Payout ratio | 21.5% | 63.9% |
| Years of dividend growth | 1 (better) | 0 |
| Dividend growth, 5Y average | – | 40.6% |
| Buyback yield | −1.0% | – |
| Shareholder yield | −0.08% | 2.7% (better) |
| Ownership | ||
| Held by institutions | 73.6% | 6.5% |
| Held by insiders | 12.3% | 0.51% |
| Insider net buying, 12 months | −$3.4M | −$44.4K (better) |
| Short interest, % of float | 2.5% | 0.92% |
Go deeper
- ACU stock overview
- ACU income statement
- ACU valuation and score
- CIX stock overview
- CIX income statement
- CIX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.